APRJ vs VXUS
Innovator Premium Income 30 Barrier ETF - April vs Vanguard Total International Stock ETF
Which is better, APRJ or VXUS?
Multi Alternative against Large Cap Blend.
VXUS has a lower expense ratio. VXUS led over 1Y, 3Y and the full window.
MarketXLS is not an investment adviser. This comparison is generated automatically from market data and is for information only. A Best mark means the better reading on that one measure, not a recommendation to buy.
Side-by-Side Comparison
| Metric | APRJ | VXUS |
|---|---|---|
| Expense Ratio | 0.79% | 0.05%Best |
| AUM | $33M | $158.1B |
| Dividend Yield | 4.80% | 2.51% |
| Holdings | 16 | 8,747 |
| YTD Return | +1.52% | +14.48%Best |
| 1Y Return | +0.32% | +22.28%Best |
| 3Y Return (annualized) | +4.08% | +20.00%Best |
| 5Y Return (annualized) | - | +8.91% |
| Volatility (annualized) | 2.2%Best | 12.3% |
| Max Drawdown | -4.7%Best | -13.6% |
| $10,000 over 3.4 years | $11,667 | $17,248Best |
| Fund Family | Innovator ETFs Trust | Vanguard (US) |
| Category | Alternative | Equity |
| Style | Multi Alternative | Large Cap Blend |
| Inception | Apr 3, 2023 | Jan 26, 2011 |
Not shown on this pair: Top 10 Weight.
Volatility and max drawdown, and the $10,000 over 3.4 years row, are measured over the window both funds cover: Apr 3, 2023 to Sep 11, 2026 (3.4 years).
APRJ vs VXUS growth
Month-end closes. Both lines start at 0% in the first month shown, so the gap between them is the difference in growth across that window. The full view covers the 3.4 years both funds cover.
APRJ vs VXUS Performance
Innovator Premium Income 30 Barrier ETF - April (APRJ) is an ETF from Innovator ETFs Trust and Vanguard Total International Stock ETF (VXUS) is an ETF from Vanguard (US). Over the past year APRJ returned +0.32% while VXUS returned +22.28%. Year to date, APRJ is up 1.52% versus a gain of 14.48% for VXUS.
Over three years, APRJ compounded at +4.08% per year against +20.00% for VXUS.
Past performance does not guarantee future results.
Risk: Volatility and Drawdowns
VXUS has been the more volatile fund, with annualized monthly volatility of 12.3% compared with 2.2% for APRJ. Lower volatility generally means a smoother ride, though it often comes with lower long-run returns.
The deepest peak-to-trough decline in our data was -4.7% for APRJ and -13.6% for VXUS. Drawdown depth is what each fund did in the worst stretch of the window measured above.
The two funds' monthly returns correlate at 0.39. They move together some of the time, and apart the rest.
Fees and Cost Over Time
APRJ charges 0.79% per year while VXUS charges 0.05%. On a $10,000 position that is $79 vs $5 annually, a gap of $74 per year that compounds over a long holding period. On income, APRJ currently yields 4.80% against 2.51% for VXUS.
You are not choosing between two funds in isolation.
Whichever of APRJ and VXUS you pick has to sit alongside everything else you own. Add the rest and see what the combination actually holds.
Free for up to 10 holdings. No account needed.
Frequently Asked Questions
Which is cheaper, APRJ or VXUS?
APRJ has an expense ratio of 0.79% while VXUS charges 0.05%. VXUS is the cheaper option, by $74 a year on a $10,000 investment.
Which performed better, APRJ or VXUS?
Over the past year APRJ returned +0.32% vs +22.28% for VXUS, so VXUS leads on 1-year performance. Past performance does not guarantee future results. This is information, not a recommendation.
Which is riskier, APRJ or VXUS?
VXUS has been the more volatile fund at 12.3% annualized versus 2.2% for APRJ. Worst drawdown: APRJ -4.7% vs VXUS -13.6%.
Should I hold both APRJ and VXUS?
APRJ and VXUS have a monthly-return correlation of 0.39, so their returns are far enough apart for the mix to behave differently from either one alone. This is information, not a recommendation.
Which pays a higher dividend, APRJ or VXUS?
APRJ yields 4.80% while VXUS yields 2.51%, so APRJ currently pays the higher dividend yield.
Is VXUS better than APRJ?
VXUS has a lower expense ratio. VXUS led over 1Y, 3Y and the full window. Which one suits a particular account depends on what it is for. This is information, not a recommendation.